DoseVault
Metabolic Compound

Mazdutide

GLP-1 / glucagon dual agonist (Innovent / Eli Lilly) submitted in China for obesity 2024.

Scientific Overview

Mazdutide (IBI362, originally LY3305677) is a weekly GLP-1R/GCGR dual agonist licensed by Innovent from Eli Lilly for greater China. Phase 3 GLORY-1 (2024) reported ~14-15% mean weight loss at 48 weeks at the 6 mg dose. NMPA submission filed in China for obesity in 2024.

Key Research Benefits

  • ✓Weight loss with energy expenditure boost
  • ✓Hepatic fat reduction
  • ✓Glucose control

Potential Side Effects

⚠GI events
⚠Decreased appetite
⚠Injection-site reactions

Research Protocols

Common Dosages

Investigational

3 -> 9 mg
Weekly SC

“Phase 3 dosing in China”

Note: Dosages listed are common research protocols found in peer-reviewed literature and clinical trials. Individual results and requirements may vary significantly in a research context.

Dose Calculator

🧮 Peptide Reconstitution Calculator

mg

Total amount of peptide in the vial.

mL

Volume of water used to mix.

mcg

Draw to this mark

120 Units

or 1.20 mL on a U-100 syringe

Concentration:2.50 mg/mL
Peptide per Unit:25.00 mcg/unit
*Always double-check your calculations. This tool is for educational purposes only.

Explore Mazdutide

Where to source

Vendors with public COAs that stock this category. Affiliate links are disclosed.

  • Limitless Life Nootropics
    FL-based research-peptide supplier with Janoshik third-party COAs and a public affiliate program at ~20%.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • SwissChems
    60+ peptide catalog with Janoshik COAs; weekly affiliate payouts.
    COA: JanoshikAffiliate disclosed
    View vendor →
  • Amino Club
    EU/US-facing vendor with a 20% first-order / 10% recurring affiliate model.
    COA: Third-partyAffiliate disclosed
    View vendor →

Mazdutide by goal

Read Mazdutide's profile filtered through specific research goals.

Mazdutide for Fat Loss

Molecular Profile

linear
modified oxyntomodulin
29 AA Sequence

Quick Reference

Status
Research Compound
Category
Metabolic
Common Dosage
3 -> 9 mg
Weekly SC

Strictly for research purposes. Not for human consumption.

Related tools

Medical Disclaimer

Information provided on DoseVault is for educational and research purposes only. This website does not advocate for the human use of peptides. Peptides are currently sold as research chemicals and are not FDA-approved for human consumption. Always consult a licensed medical professional before considering any protocol.